NEOSPORIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Neosporin, and what generic alternatives are available?
Neosporin is a drug marketed by Glaxosmithkline and Monarch Pharms and is included in three NDAs.
The generic ingredient in NEOSPORIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOSPORIN?
- What are the global sales for NEOSPORIN?
- What is Average Wholesale Price for NEOSPORIN?
Summary for NEOSPORIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 4 |
| Drug Prices: | Drug price information for NEOSPORIN |
| DailyMed Link: | NEOSPORIN at DailyMed |
Recent Clinical Trials for NEOSPORIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yale University | Phase 1 |
| Bill and Melinda Gates Foundation | Phase 1 |
| Jacksonville Center For Clinical Research | N/A |
US Patents and Regulatory Information for NEOSPORIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | NEOSPORIN | neomycin sulfate; polymyxin b sulfate | CREAM;TOPICAL | 050176-002 | Jan 14, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Monarch Pharms | NEOSPORIN | gramicidin; neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 060582-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Monarch Pharms | NEOSPORIN G.U. IRRIGANT | neomycin sulfate; polymyxin b sulfate | SOLUTION;IRRIGATION | 060707-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
